Retroviral vectors expressing tumor necrosis factor (TNF)
US5652130A · kind A · utility
7Cited by
13References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 29, 1994 |
| Grant date | Jul 29, 1997 |
| Priority date | — |
| Expiry date | Nov 29, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/13062
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A drug delivery virion which contains an expression system for the desired protein active ingredient packaged in an envelope derived from a retrovirus is especially useful in administering materials which need to cross cell membranes in order to serve their function.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.